ePrints

Anti-SARS-CoV2 antibody responses are attenuated in patients with inflammatory bowel disease treated with infliximab

Lookup NU author(s): Professor Chris LambORCiD

Downloads

• Accepted version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Publication metadata

Author(s): Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J, Cooney R, Croft NM, Hart AL, Irving PM, Kok KB, Lamb CA, Limdi JK, Macdonald J, McGovern DPB, Mehta SJ, Murray CD, Patel KV, Pollok RCG, Raine T, Russell RK, Selinger CP, Smith PJ, Bowden J, McDonald TJ, Lees CW, Sebastian S, Powell N, Ahmad T

Publication type: Article

Publication status: Published

Journal: Gut

Year: 2021

Volume: 70

Issue: 5

Pages: 865-875

Print publication date: 01/05/2021

Online publication date: 22/03/2021

Acceptance date: 18/02/2021

Date deposited: 21/04/2021

ISSN (print): 0017-5749

ISSN (electronic): 1468-3288

Publisher: BMJ Publishing Group

URL: https://doi.org/10.1136/gutjnl-2021-324388

DOI: 10.1136/gutjnl-2021-324388

Altmetrics

Share